9th May 2020
Exponential Technologies need micro-organism cultures to test software
Exponential Technologies has design of experiments (DOE) software based on small-data AI, which can accelerate the scaling process of COVID-19 vaccine production particularly on bioreactors.
Their software optimises the process parameters and nutrient mixture recipes for bioreactors and allows for a rapid scale-up (moving from a smaller size reactor to a larger one).
The team is looking for labs working on COVID-19 vaccine R&D who have a need to scale-up with bioreactors.
In order to develop a more robust approach, the team is looking to test their software on as many micro-organism cultures as possible.
Anyone interested in co-development or being a pilot should get in touch.
Software licences and the time commitment from the Exponential Technologies will be offered free of charge to anyone working on COVID-19 vaccine.
ASK: Research contributors needed for CON-VICE study
University of Luxembourg needs European researchers to get in touch
OFFER: Funding available for COVID-19 research
Fondation Air Liquide are looking to fund European projects
ASK: Supporting the immunocompromised
Partners sought to advance neutralising antibody